JP2023011759A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023011759A5 JP2023011759A5 JP2022172687A JP2022172687A JP2023011759A5 JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5 JP 2022172687 A JP2022172687 A JP 2022172687A JP 2022172687 A JP2022172687 A JP 2022172687A JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2020/028575 WO2022018875A1 (ja) | 2020-07-22 | 2020-07-22 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
| JP2022538564 | 2020-07-22 | ||
| JP2022538564A JPWO2022018875A1 (enrdf_load_stackoverflow) | 2020-07-22 | 2020-07-22 | |
| JP2021121960A JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021121960A Division JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023011759A JP2023011759A (ja) | 2023-01-24 |
| JP2023011759A5 true JP2023011759A5 (enrdf_load_stackoverflow) | 2024-08-07 |
Family
ID=79729374
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538564A Pending JPWO2022018875A1 (enrdf_load_stackoverflow) | 2020-07-22 | 2020-07-22 | |
| JP2021121960A Active JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
| JP2022172687A Pending JP2023011759A (ja) | 2020-07-22 | 2022-10-27 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538564A Pending JPWO2022018875A1 (enrdf_load_stackoverflow) | 2020-07-22 | 2020-07-22 | |
| JP2021121960A Active JP7168734B2 (ja) | 2020-07-22 | 2021-07-26 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
Country Status (3)
| Country | Link |
|---|---|
| JP (3) | JPWO2022018875A1 (enrdf_load_stackoverflow) |
| KR (2) | KR102550455B1 (enrdf_load_stackoverflow) |
| WO (1) | WO2022018875A1 (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022013593A2 (pt) | 2020-01-10 | 2022-09-13 | Immuneering Corp | Inibidores de mek e usos terapêuticos dos mesmos |
| MX2024000908A (es) * | 2021-07-21 | 2024-02-07 | Chugai Pharmaceutical Co Ltd | Metodo para producir derivado de arilamida. |
| US20250262194A1 (en) * | 2022-04-20 | 2025-08-21 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical for treating or preventing cancer |
| EP4551558A2 (en) * | 2022-07-08 | 2025-05-14 | Nested Therapeutics, Inc. | Mitogen-activated protein kinase (mek) inhibitors |
| WO2025007811A1 (zh) * | 2023-07-06 | 2025-01-09 | 成都华健未来科技有限公司 | 一类芳香酰胺类衍生物及其用途 |
| TW202530185A (zh) * | 2023-09-21 | 2025-08-01 | 日商中外製藥股份有限公司 | 芳基醯胺衍生物的製造方法 |
| WO2025146040A1 (zh) * | 2024-01-01 | 2025-07-10 | 华健未来（成都）科技股份有限公司 | 芳香酰肼类衍生物及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8084645B2 (en) * | 2003-09-19 | 2011-12-27 | Chugai Seiyaku Kabushiki Kaisha | 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors |
| AU2004293018B2 (en) * | 2003-11-19 | 2010-02-18 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
| TWI361066B (en) * | 2004-07-26 | 2012-04-01 | Chugai Pharmaceutical Co Ltd | 5-substituted-2-phenylamino benzamides as mek inhibitors |
| AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| CN103140221A (zh) * | 2010-08-10 | 2013-06-05 | 盐野义制药株式会社 | 新型杂环衍生物和含有其的药物组合物 |
| US20130123255A1 (en) * | 2011-11-10 | 2013-05-16 | Chugai Seiyaku Kabushiki Kaisha | Combination of a pi3k inhibitor and a mek inhibitor |
| JP2016034900A (ja) * | 2012-11-26 | 2016-03-17 | 中外製薬株式会社 | ５−置換−２−フェニルアミノ−ベンズアミド類の製造方法 |
| CN104803996A (zh) * | 2014-01-27 | 2015-07-29 | 天津滨江药物研发有限公司 | 作为蛋白激酶抑制剂的氮杂环类化合物及其制备方法 |
| CN105384738B (zh) * | 2014-08-21 | 2017-08-29 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途 |
| AR121078A1 (es) | 2020-01-22 | 2022-04-13 | Chugai Pharmaceutical Co Ltd | Derivados de arilamida con actividad antitumoral |
| BR112023000883A2 (pt) | 2020-07-22 | 2023-02-07 | Chugai Pharmaceutical Co Ltd | Composição contendo derivado de arilamida |
-
2020
- 2020-07-22 JP JP2022538564A patent/JPWO2022018875A1/ja active Pending
- 2020-07-22 WO PCT/JP2020/028575 patent/WO2022018875A1/ja not_active Ceased
-
2021
- 2021-07-21 KR KR1020210095267A patent/KR102550455B1/ko active Active
- 2021-07-26 JP JP2021121960A patent/JP7168734B2/ja active Active
-
2022
- 2022-10-27 JP JP2022172687A patent/JP2023011759A/ja active Pending
-
2023
- 2023-06-26 KR KR1020230081877A patent/KR20230098762A9/ko active Pending